Amydis Diagnostics' Grant - III Round

Amydis Diagnostics raised a round of funding on October 09, 2017. Investors include National Institutes of Health.

Amydis is a privately-held pharmaceutical company focused on developing chemistry to detect diseases that involve the presence of amyloid proteins. The company's mission is to develop a universal, non…

Articles about Amydis Diagnostics' Grant - III Round: